Funds research to develop monoclonal antibody therapies for specific Flaviviruses, advancing clinical candidates and EU outbreak preparedness.
This grant supports research to develop monoclonal antibodies against key emerging viruses, advancing candidates through preclinical and early clinical stages to boost EU pandemic preparedness.
This grant funds research to discover and develop new small molecule antivirals for specific epidemic-prone viruses, supporting projects from early discovery through early-stage clinical studies.
Funds research to develop new antibacterial and antifungal therapies targeting specific drug-resistant pathogens to combat antimicrobial resistance and strengthen EU health leadership.
Accelerating Research and Development of Next Generation Vaccines against Malaria supports researchers developing highly effective, long-lasting vaccines to protect against malaria and inform other vaccine work.
This grant funds research sites to improve influenza and respiratory pathogen vaccine effectiveness through surveillance, coordination, household transmission, and immunogenicity studies in the US Flu VE Network.